Actin Filament Depolymerization
Adult Stem Cells
Embryonic Stem Cells
Induced Pluripotent Stem Cells
The Role of Actin and Myosin in Non-muscle Cells
Actin Polymerization and Cell Motility
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Feb 12, 2026

Isolation and Enrichment of Human Adipose-derived Stromal Cells for Enhanced Osteogenesis
Published on: January 12, 2015
Li Chen1, Huimin Hu2, Weimin Qiu1
1Molecular Endocrinology Laboratory (KMEB), Odense University Hospital, University of South Denmark, DK-5000 Odense C, Denmark.
This study explored how changes in the actin cytoskeleton affect the ability of human stromal stem cells to become fat cells. The researchers found that breaking down actin filaments increased the number of mature fat cells. In contrast, stabilizing actin reduced fat cell formation. They also discovered that the effects of actin on differentiation depend on the activity of LIM domain kinase 1 and involve changes in ERK and Smad2 signaling. These findings suggest that actin dynamics play a key role in controlling stem cell fate. The results help clarify how the structure of the cell's internal framework influences its ability to specialize into different cell types.
13:26Visualization and Quantification of Mesenchymal Cell Adipogenic Differentiation Potential with a Lineage Specific Marker
Published on: March 31, 2018
06:50Isolation of Adipogenic and Fibro-Inflammatory Stromal Cell Subpopulations from Murine Intra-Abdominal Adipose Depots
Published on: August 16, 2020
Area of Science:
Background:
Human stromal stem cells undergo morphological and functional changes during adipocyte differentiation, suggesting cytoskeletal involvement. While prior research has shown that actin microfilaments contribute to cell shape and motility, their specific role in adipogenesis remains unclear. This gap motivated a closer examination of how actin dynamics influence lineage commitment. The cytoskeleton is known to regulate cell signaling and gene expression, but its direct impact on adipogenic differentiation is not fully understood. Researchers have identified actin depolymerizing factors as key regulators of cytoskeletal reorganization. However, no prior work had resolved the connection between actin filament stability and adipocyte formation. This uncertainty drove the need to test whether modulating actin dynamics could alter differentiation outcomes. Understanding this relationship may provide new insights into controlling stem cell fate. The study aimed to clarify how actin microfilament changes affect adipogenesis in human stromal stem cells.
Purpose Of The Study:
This study aimed to determine how actin microfilament dynamics influence adipocyte differentiation in human stromal stem cells. The researchers focused on the role of actin depolymerizing factors in this process. They hypothesized that changes in actin organization could directly affect differentiation outcomes. To test this, they manipulated actin filament stability using genetic and pharmacological tools. The goal was to observe how these changes impacted the formation of mature adipocytes. The study also sought to identify the signaling pathways involved in this process. By linking cytoskeletal reorganization to cell fate decisions, the researchers aimed to uncover new regulatory mechanisms. Their findings could help refine methods for directing stem cell differentiation in regenerative medicine.
Main Methods:
The researchers used siRNA to knock down Cofilin 1 and Destrin, two major actin depolymerizing factors. They also treated cells with Phalloidin to stabilize actin filaments. Cytochalasin D was used to disrupt the actin cytoskeleton. Adipocyte differentiation was assessed by counting mature adipocytes and measuring gene expression. The team analyzed the expression of ADIPOQ, LPL, PPARG, and FABP4 as markers of differentiation. They tested the role of LIM domain kinase 1 as an upstream regulator of Cofilin 1. ERK and Smad2 signaling were evaluated to determine their involvement in the process. The effects of ERK inhibition on differentiation were also examined using U0126. These methods allowed the researchers to link actin dynamics to adipogenic outcomes.
Main Results:
Disrupting actin filaments with Cytochalasin D increased the number of mature adipocytes. This was accompanied by higher expression of adipocyte-specific genes. In contrast, stabilizing actin with Phalloidin or knocking down Cofilin 1 and Destrin reduced differentiation. The effects of Cofilin 1 were mediated through LIM domain kinase 1 activity. Inhibiting LIMK1 enhanced adipocyte differentiation by reducing actin polymerization. Cytochalasin D also inhibited ERK and Smad2 signaling, which correlated with increased differentiation. Phalloidin treatment enhanced ERK and Smad2 signaling but suppressed differentiation. This suppression was reversed by the ERK inhibitor U0126. These results suggest that actin dynamics regulate adipogenesis through multiple signaling pathways.
Conclusions:
The findings suggest that actin depolymerization promotes adipocyte differentiation in human stromal stem cells. The researchers propose that this effect is mediated through LIMK1 and Cofilin 1 activity. Disrupting actin filaments appears to enhance differentiation by inhibiting ERK and Smad2 signaling. Stabilizing actin filaments has the opposite effect, reducing differentiation. The study supports a direct link between cytoskeletal reorganization and cell fate decisions. The authors suggest that actin dynamics may serve as a regulatory mechanism for lineage commitment. Their results highlight the importance of actin microfilaments in adipogenesis. These conclusions align with the observed changes in gene expression and signaling pathways.
Actin depolymerization enhances adipocyte differentiation in human stromal stem cells.
The study focused on Cofilin 1 (CFL1) and Destrin (DSTN).
They used Cytochalasin D to disrupt the actin cytoskeleton.
LIMK1 regulates Cofilin 1 activity, which affects actin polymerization and differentiation.
ERK and Smad2 signaling were inhibited by actin disruption, enhancing differentiation.
They used the ERK inhibitor U0126 to reverse the effects of Phalloidin treatment.